Telmisartan
Brand name: Telmisartan
Rank #459 of 500 drugs by total cost
$16.4M
Total Cost
334,601
Total Claims
$16.4M
Total Cost
11,815
Prescribers
$49
Cost per Claim
46,533
Beneficiaries
827,512
30-Day Fills
$1,389
Avg Cost/Provider
28
Avg Claims/Provider
About Telmisartan
Telmisartan (sold as Telmisartan) was prescribed 334,601 times by 11,815 Medicare Part D providers in 2023, costing the program $16.4M. At $49 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 456 | Clonidine (Clonidine) | $16.7M | 112,710 |
| 457 | Glucagon (Gvoke Hypopen 2-Pack) | $16.6M | 31,523 |
| 458 | Bosentan (Bosentan) | $16.5M | 2,765 |
| 459 | Telmisartan (Telmisartan) | $16.4M | 334,601 |
| 460 | Letermovir (Prevymis) | $16.1M | 2,144 |
| 461 | Fluphenazine Hcl (Fluphenazine Hcl) | $16.0M | 73,051 |
| 462 | Nivolumab (Opdivo) | $16.0M | 1,275 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology